Photo by freestocks from unsplash
tality, and interventions. PLoS Medicine, 10, e1001484. Piel, F.B., Steinberg, M.H. & Rees, D.C. (2017) Sickle cell disease. New England Journal of Medicine, 377, 305. Powars, D.R., Chan, L.S., Hiti,… Click to show full abstract
tality, and interventions. PLoS Medicine, 10, e1001484. Piel, F.B., Steinberg, M.H. & Rees, D.C. (2017) Sickle cell disease. New England Journal of Medicine, 377, 305. Powars, D.R., Chan, L.S., Hiti, A., Ramicone, E. & Johnson, C. (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore), 84, 363– 376. van Tuijn, C.F.J., Schimmel, M., van Beers, E.J., Nur, E. & Biemond, B.J. (2017) Prospective evaluation of chronic organ damage in adult sickle cell patients: a seven-year follow-up study. American Journal of Hematology, 92, E584–E590. Vitrano, A., Calvaruso, G., Lai, E., Colletta, G., Quota, A., Gerardi, C., Concetta Rigoli, L., Pitrolo, L., Cuccia, L., Gagliardotto, F., Filosa, A., Caruso, V., Argento, C., Campisi, S., Rizzo, M., Prossomariti, L., Fidone, C., Fustaneo, M., Di Maggio, R. & Maggio, A. (2017) The era of comparable life expectancy between thalassaemia major and intermedia: is it time to revisit the major-intermedia dichotomy? British Journal of Haematology, 176, 124–130.
Journal Title: British Journal of Haematology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!